China Biologic Products Company Profile (NASDAQ:CBPO)

About China Biologic Products (NASDAQ:CBPO)

China Biologic Products logoChina Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CBPO
  • CUSIP: N/A
  • Web: www.chinabiologic.com
Capitalization:
  • Market Cap: $2.18288 billion
  • Outstanding Shares: 27,238,000
Average Prices:
  • 50 Day Moving Avg: $93.15
  • 200 Day Moving Avg: $103.13
  • 52 Week Range: $79.04 - $125.99
P/E:
  • Trailing P/E Ratio: 21.10
  • Foreward P/E Ratio: 13.83
  • P/E Growth: 1.51
Sales & Book Value:
  • Annual Revenue: $344.89 million
  • Price / Sales: 6.40
  • Book Value: $20.26 per share
  • Price / Book: 4.00
Profitability:
  • EBITDA: $155.64 million
  • Net Margins: 31.55%
  • Return on Equity: 21.86%
  • Return on Assets: 18.83%
Debt:
  • Current Ratio: 5.21%
  • Quick Ratio: 3.24%
Misc:
  • Average Volume: 300,344 shs.
  • Beta: 1.75
  • Short Ratio: 6.28
 

Frequently Asked Questions for China Biologic Products (NASDAQ:CBPO)

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

How were China Biologic Products' earnings last quarter?

China Biologic Products, Inc. (NASDAQ:CBPO) announced its quarterly earnings data on Wednesday, August, 2nd. The company reported $1.35 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.30 by $0.05. The business had revenue of $89.28 million for the quarter, compared to analyst estimates of $97.33 million. China Biologic Products had a net margin of 31.55% and a return on equity of 21.86%. China Biologic Products's revenue was down 2.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.26 earnings per share. View China Biologic Products' Earnings History.

Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?

3 brokerages have issued twelve-month target prices for China Biologic Products' stock. Their forecasts range from $135.00 to $140.00. On average, they anticipate China Biologic Products' stock price to reach $137.50 in the next twelve months. View Analyst Ratings for China Biologic Products.

Who are some of China Biologic Products' key competitors?

Who are China Biologic Products' key executives?

China Biologic Products' management team includes the folowing people:

  • David Gao, Chairman of the Board, President, Chief Executive Officer
  • Ming Yang CPA, Chief Financial Officer
  • Zhijing Liu, Corporate Vice President
  • Ming Yin, Senior Corporate Vice President
  • Gang Yang, Corporate Vice President, General Manager of Guizhou Taibang
  • David Hui Li, Director
  • Joseph J. Chow, Independent Director
  • Wenfang Liu, Independent Director
  • Yungang Lu, Independent Director
  • Xiaosheng Shao, Independent Director

How do I buy China Biologic Products stock?

Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Biologic Products' stock price today?

One share of China Biologic Products stock can currently be purchased for approximately $81.06.


MarketBeat Community Rating for China Biologic Products (NASDAQ CBPO)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  273
MarketBeat's community ratings are surveys of what our community members think about China Biologic Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $137.50 (69.63% upside)
Consensus Price Target History for China Biologic Products (NASDAQ:CBPO)
Price Target History for China Biologic Products (NASDAQ:CBPO)
Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/4/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
5/30/2017Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral -> NeutralMediumView Rating Details
3/3/2017Morgan StanleyReiterated RatingOverweight$135.00N/AView Rating Details
7/5/2016Credit Suisse GroupUpgradeNeutral -> OutperformN/AView Rating Details
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00N/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
Earnings by Quarter for China Biologic Products (NASDAQ:CBPO)
Earnings History by Quarter for China Biologic Products (NASDAQ CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/20176/30/2017$1.30$1.35$97.33 million$89.28 millionViewListenView Earnings Details
2/23/2017Q416$0.84$0.95$76.61 million$77.60 millionViewN/AView Earnings Details
11/2/2016Q316$1.05$1.22$88.46 million$86.50 millionViewN/AView Earnings Details
8/4/2016Q216$1.16$1.10$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$0.99$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87$70.35 millionViewN/AView Earnings Details
11/5/2014Q4 14$0.43$0.48$63.00 million$68.92 millionViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
Current Year EPS Consensus Estimate: $4.48 EPS
Next Year EPS Consensus Estimate: $5.86 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for China Biologic Products (NASDAQ:CBPO)
Insider Ownership Percentage: 2.73%
Institutional Ownership Percentage: 72.82%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2017Zhijing Cbpo LiuInsiderSell7,500$116.49$873,675.00View SEC Filing  
3/2/2017Sean ShaoDirectorSell20,000$100.78$2,015,600.00View SEC Filing  
3/1/2017David GaoCEOSell116,653$100.63$11,738,791.39View SEC Filing  
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.44View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.00View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for China Biologic Products (NASDAQ:CBPO)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
Source:
DateHeadline
seekingalpha.com logoWeek In Review: Shanghai Pharma Bids In Cardinal China's $1.5 Billion Auction
seekingalpha.com - October 15 at 4:33 PM
nasdaq.com logoFirst Week of CBPO November 17th Options Trading
www.nasdaq.com - October 13 at 5:39 PM
rttnews.com logoChina Biologic Products (CBPO) Fell To A New Low After Acquisition
www.rttnews.com - October 13 at 5:39 PM
finance.yahoo.com logoChina Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition
finance.yahoo.com - October 13 at 5:39 PM
finance.yahoo.com logoChina Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017
finance.yahoo.com - October 13 at 5:39 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 5:39 PM
streetinsider.com logoChina Biologic Products (CBPO) Reports Acquisition of TianXinFu ... - StreetInsider.com
www.streetinsider.com - October 13 at 3:54 AM
americanbankingnews.com logo China Biologic Products, Inc. (CBPO) Given $131.67 Consensus Target Price by Brokerages
www.americanbankingnews.com - October 13 at 12:26 AM
rttnews.com logoINFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints
www.rttnews.com - October 12 at 10:51 PM
reuters.com logoBRIEF-China Biologic agrees to acquire Tianxinfu from PWM
www.reuters.com - October 12 at 5:49 PM
streetinsider.com logoChina Biologic Products (CBPO) Reports Acquisition of TianXinFu from PW Medtech Group
www.streetinsider.com - October 12 at 5:49 PM
finance.yahoo.com logoChina Biologic Agrees to Acquire TianXinFu from PWM
finance.yahoo.com - October 12 at 5:49 PM
streetinsider.com logoForm 6-K China Biologic Products For: Oct 10
www.streetinsider.com - October 11 at 6:31 PM
streetinsider.com logoChina Biologic Products (CBPO) Granted from Approval Chinese FDA for Commercial Manufacturing of Human ... - StreetInsider.com
www.streetinsider.com - October 10 at 6:13 PM
streetinsider.com logoChina Biologic Products (CBPO) Granted from Approval Chinese FDA for Commercial Manufacturing of Human Fibrinogen
www.streetinsider.com - October 10 at 3:45 AM
reuters.com logoBRIEF-China Biologic receives approval for commercial manufacturing of human fibrinogen
www.reuters.com - October 9 at 5:40 PM
finance.yahoo.com logoChina Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen
finance.yahoo.com - October 9 at 5:40 PM
finance.yahoo.com logoChina Biologic Products Holdings, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 3, 2017
finance.yahoo.com - October 3 at 4:53 PM
finance.yahoo.com logoChina Biologic Products Holdings, Inc. :CBPO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017
finance.yahoo.com - October 2 at 3:31 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products Holdings, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 3:31 PM
prnewswire.com logoChina Tissue Engineered - Skin Substitutes Market Outlook to 2024
www.prnewswire.com - September 28 at 5:03 PM
americanbankingnews.com logo China Biologic Products, Inc. (CBPO) Given $131.67 Consensus Target Price by Analysts
www.americanbankingnews.com - September 20 at 6:08 PM
americanbankingnews.com logo China Biologic Products, Inc. (CBPO) Given $131.67 Average Target Price by Analysts
www.americanbankingnews.com - September 10 at 6:24 PM
americanbankingnews.com logo Analysts Expect China Biologic Products, Inc. (CBPO) Will Announce Earnings of $1.30 Per Share
www.americanbankingnews.com - September 10 at 2:16 PM
americanbankingnews.com logoContrasting China Biologic Products (CBPO) and RA PHARMCTL INC (RARX)
www.americanbankingnews.com - September 9 at 11:04 AM
finance.yahoo.com logoChina Biologic Products Holdings Inc
finance.yahoo.com - August 11 at 4:17 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.
finance.yahoo.com - August 10 at 6:12 PM
finance.yahoo.com logoIHS Markit Score upgrades China Biologic Products Holdings Inc to 34 out of 100, despite ranking positively in only one IHS Markit category.
finance.yahoo.com - August 9 at 10:13 PM
finance.yahoo.com logoFeatured Company News – MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients
finance.yahoo.com - August 9 at 5:11 PM
americanbankingnews.com logoFY2018 EPS Estimates for China Biologic Products, Inc. Decreased by Jefferies Group (NASDAQ:CBPO)
www.americanbankingnews.com - August 7 at 9:30 AM
seekingalpha.com logoChina Biologic Products' (CBPO) CEO David Gao on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 4:20 PM
americanbankingnews.com logoJefferies Group LLC Reaffirms Buy Rating for China Biologic Products, Inc. (CBPO)
www.americanbankingnews.com - August 5 at 7:14 AM
streetinsider.com logoForm 8-A12B/A China Biologic Products
www.streetinsider.com - August 4 at 10:18 PM
americanbankingnews.com logoChina Biologic Products, Inc. (CBPO) Posts Earnings Results, Beats Expectations By $0.05 EPS
www.americanbankingnews.com - August 4 at 9:42 PM
americanbankingnews.com logo Brokerages Expect China Biologic Products, Inc. (NASDAQ:CBPO) to Announce $1.32 Earnings Per Share
www.americanbankingnews.com - August 4 at 8:28 PM
americanbankingnews.com logoBrokerages Expect China Biologic Products, Inc. (CBPO) to Announce $1.32 Earnings Per Share
www.americanbankingnews.com - August 4 at 4:52 PM
nasdaq.com logoChina Biologic Products Inc. Reveals 9% Advance In Q2 Profit - Nasdaq
www.nasdaq.com - August 3 at 6:26 PM
finance.yahoo.com logoChina Biologic Products posts 2Q profit
finance.yahoo.com - August 3 at 6:26 PM
rttnews.com logoChina Biologic Products Inc. Reveals 9% Advance In Q2 Profit
www.rttnews.com - August 2 at 5:43 PM
rttnews.com logoChina Biologic Products Inc. Reveals 9% Advance In Q2 Profit
www.rttnews.com - August 2 at 5:43 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the Second Quarter of 2017
finance.yahoo.com - August 2 at 5:43 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the Second Quarter of 2017
finance.yahoo.com - August 2 at 5:43 PM
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT
finance.yahoo.com - July 24 at 11:54 AM
americanbankingnews.com logo China Biologic Products, Inc. (CBPO) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 20 at 12:42 PM
finance.yahoo.com logoChina Biologic Products to Report Second Quarter of 2017 Financial Results
finance.yahoo.com - July 19 at 6:09 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : July 17, 2017
finance.yahoo.com - July 17 at 5:20 PM
americanbankingnews.com logoChina Biologic Products, Inc. (NASDAQ:CBPO) Expected to Post Earnings of $1.36 Per Share
www.americanbankingnews.com - July 13 at 2:16 PM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : July 6, 2017
finance.yahoo.com - July 6 at 6:14 PM
finance.yahoo.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 4, 2017
finance.yahoo.com - July 4 at 9:47 PM
americanbankingnews.com logoChina Biologic Products, Inc. (NASDAQ:CBPO) Short Interest Down 31.7% in June
www.americanbankingnews.com - July 1 at 7:06 AM

Social

Chart

China Biologic Products (CBPO) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.